A unicorn startup that originally set out to hasten clinical studies for biopharma partners dug further into its revised path of internal drug development by linking arms with Sanofi in a pact that the biotech’s CEO said originated from the top. TrialSpark and the Big Pharma on Tuesday committed to
Pfizer, GSK, Janssen, Regeneron, Boehringer Ingelheim and at least a half dozen other companies are calling on the FDA to provide significantly more clarity in its draft guidance from this summer on clinical outcome assessments, which are a type of patient experience. The draft is the third in a ser…
A pair of new drugs offer something that most Americans desperately want: a way to lose weight.
The Global Peptide Synthesis Market Size was USD 4.3 Billion in 2021 and is projected to reach USD 6.2 Billion by 2030, exhibiting a CAGR of 7.7% during...
The Federal Reserve again raised interest rates last week, which is expected to increase the borrowing costs across the economy, including raising the costs of expanding a business. That means that demand could slow, and demand for employment may slow as well, leading to a c…
The U.S. is leading the safety needles market in North America and is set to witness a CAGR of 7.5% over the forecast period. The market for safety needles in the Germany is set to expand at a CAGR of 10.6% by the end of 2032 owing to the emergence of established guidelines on infection prevention w…
Biotechnology Market to Reach US$ 1,303.1 Billion at a CAGR of 12.3% by 2027 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline, Johnson and Johnson Medgadget
The persuasive Blood Glucose Monitoring System report contains finest explanation about the strategic profiling of the key players in the market,
The global “Peptide Therapeutics Market” report aims to provide a detailed analysis of the factors that influence the global business adoption and
The global “Recombinant Therapeutic Antibodies and Proteins Market” report aims to provide a detailed analysis of the factors that influence the global
Manufacturing base of pharmaceutical company Novo Nordisk in Tianjin
Your future burger is probably lying under your feet.
In pics: manufacturing base of pharmaceutical company Novo Nordisk in Tianjin-
The company’s diabetes treatment is also in testing as an obesity drug.
Biotech stocks remain undervalued, but investors could start building a position.
Ozempic was originally created as a medication for the pre-diabetic — and now, it’s become a weight loss strategy for the rich and famous.
FRIDAY, Sept. 22, 2022 (HealthDay News) -- There appears to be a causal association for genetic predisposition to smoking with worse functional outcome after ischemic stroke, according to a study published online Sept. 21 in Neurology. Zhizhong Zhang, Ph.D., from Jinling Hospital and Medical School…
The PTAB held an Oral Hearing between Junior Party the University of California, the University of Vienna, and Emmanuelle Charpentier (collectively,...
There are many Americans who depend on life-saving drugs to survive, but are unable to afford them. Those who rely on prescription drugs like insulin, Epipens and inhalers, cannot afford skipping doses or just not opting to use them. Manufacturers are racking up prices of insulin to anywhere from…
Here’s the latest on the Triangle labor market, with the most recent analysis of data gathered by WRAL and presented in the WRAL TechWire Jobs Report.